Q3 2025 Earnings Call Transcript October 29, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.6, ...

This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...

During this conference call, we will make forward-looking statements within the meaning of federal securities laws. For a ...

At this time, I would like to welcome everyone to the Murphy USA Third Quarter 2025 Earnings Conference Call. With me are R.